IVF SCHEDULE 13G/A: SEC filing
An institutional holder
Filed with the SEC on · accession 0000902664-26-004117
IVF filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Oct 9, 2026. An institutional holder filed an amended Schedule 13G for INVO Fertility, Inc. (IVF), indicating a change in beneficial ownership position. The stock moved -1.7% by the first close after the filing.
Summary of the filing
An institutional holder filed an amended Schedule 13G for INVO Fertility, Inc. (IVF), indicating a change in beneficial ownership position. The filing is a routine passive ownership disclosure.
Key details
How IVF stock reacted
Close before
$2.96
Oct 8, 2026
First close after
-1.70%
$2.91
5 trading days
-20.15%
$2.36
Since filing
-37.51%
$1.85
✦ Ask GOAX AI about this filing — what it means for IVF, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for IVF?
Click hereFrequently asked questions
What did IVF file with the SEC on Oct 9, 2026?
IVF filed a SCHEDULE 13G/A (SEC filing). An institutional holder filed an amended Schedule 13G for INVO Fertility, Inc. (IVF), indicating a change in beneficial ownership position. The filing is a routine passive ownership disclosure.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
How did IVF stock react to this filing?
IVF closed at $2.96 before the filing and $2.91 on Oct 9, 2026 (-1.70%). Five trading days later: $2.36 (-20.15%).
Other IVF SEC filings
- 8-K · SEC filingAug 17, 2026
- 10-Q · SEC filingAug 14, 2026
- 424B3 · Secondary offeringAug 7, 2026
- 8-K · Material agreementJul 24, 2026
- S-1 · AcquisitionJul 24, 2026
- 8-K · AcquisitionJun 25, 2026
- DEF 14A · Board changeJun 23, 2026
- 8-K · SEC filingJun 22, 2026
- 10-Q · SEC filingJun 22, 2026
- 10-K/A · RestatementJun 12, 2026
Get alerts when IVF files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days